Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-18

Clinical Trial Update: Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Green Propolis Extract (EPP-AF) effects on inflammation in patients with chronic kidney disease requiring chronic dialysis. Completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Green Propolis Extract (EPP-AF)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Chronic Kidney Disease Requiring Chronic Dialysis | Phase 1, Phase 2 | Status: COMPLETED